Enhanced Cancer-targeted Drug Delivery Using Precoated Nanoparticles

Lu Yu,Mingyu Xu,Wenwen Xu,Wei Xiao,Xue-hua Jiang,Ling Wang,Huile Gao

DOI: https://doi.org/10.1021/acs.nanolett.0c03982

IF: 10.8

2020-11-24

Nano Letters

Abstract:While protein coronas (PCs) are an important barrier in the clinical application of nanomedicines, the specific effects of PCs on nanoparticles (NPs) <i>in vivo</i> are unclear. Herein, we demonstrated that PCs from clinical sources greatly influenced the active targeting capacities of transferrin-modified NPs (Tf-NPs). Compared to PCs from healthy volunteers, PCs from the plasma of patients with nonsmall cell lung cancer (NSCLC) decreased the A549 uptake of Tf-NPs to a greater degree. The PC proteome revealed that this difference may be mediated by certain proteins in plasma. To attenuate the negative influence of PCs from patients, precoating Tf-NPs with PCs derived from healthy mice significantly enhanced active targeting capacities. Paclitaxel-loaded Tf-NPs with PCs derived from healthy mice showed the strongest antitumor effects in mice with NSCLC. This work illustrates the influence of PCs of ligand-modified NPs in clinical practice and proposes the use of corona-enabled active targeting for precision nanomedicine.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.nanolett.0c03982?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.nanolett.0c03982</a>.Details related to materials and methods; characterization of particle size and zeta (ζ) potential of bare NPs and NPs with PC (Table S1); the amount of protein adsorbed on NPs (Table S2); the most abundant proteins (top 30) identified in the PC of NPs from human sources (Table S3); the most abundant proteins (top 30) identified in the PC of NPs from murine sources (Table S4); microscopic observation of coumarin⁺ A549 cells (Figures S1 and S3); normalized fluorescence intensity in A549 cells (Figures S2 and S4); schematic description of the experimental design for studies of <i>in vivo</i> mouse PC formation (Figure S5); the intensity diameter distribution of NPs with/without <i>in vivo</i> mouse-derived PC (Figure S6); TEM images of NPs with/without <i>in vivo</i> mouse-derived PC (Figure S7); microscopy observation of coumarin⁺ LL/2 cells (Figures S8 and S10); the normalized fluorescence intensity in LL/2 cells (Figures S9 and S11); fluorescence intensity in organs and tumor 24 h post-injection (Figure S12); tumor size in all mouse groups (Figure S13); coomassie brilliant blue-stained SDS-PAGE gel of PCs associated with NPs (Figure S14); classification of PCs according to physiological function (Figure S15); Venn diagrams depicting the number of unique proteins identified in the <i>in vitro</i>-formed coronas and their respective overlap (Figure S16); Venn diagrams depicting the number of unique proteins identified in the <i>in vivo</i>-formed coronas and their respective overlap (Figure S17); and evaluation of NP safety and IgE concentrations in serum from all murine groups (Figure S18) (<a class="ext-link" href="/doi/suppl/10.1021/acs.nanolett.0c03982/suppl_file/nl0c03982_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology